Search

everythinglearnresearchcommunity

for

Search:↓

Isoallopregnanolone may be a safe and effective treatment for reducing tics in a mouse model of Tourette syndrome.

Inflammation in rheumatoid arthritis increases steroid activation in cells, reducing inflammation.

Advancements in understanding, diagnosing, and managing congenital adrenal hyperplasia have improved treatment and long-term outcomes.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Oral cyclosporine combined with Pantogar® effectively treats twenty-nail dystrophy.

Testosterone metabolism in balding scalp cells may not be the main cause of hair loss.

Prostaglandin D2 increases testosterone levels in skin cells through reactive oxygen species, not enzymes, which could lead to new hair loss treatments.

A combination of cyclosporine and oral corticosteroid successfully regrew hair in a 19-year-old with alopecia universalis.

Calcipotriol scalp solution works better than coal tar shampoo for treating scalp psoriasis and is safe for long-term use.

Combining baricitinib with low-dose corticosteroids significantly improved severe hair loss in eight patients.

Dienogest and combined oral contraceptives are equally effective for endometriosis, but COC may reduce painful intercourse more.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Women with effluvium have higher levels of certain urinary steroids, possibly due to stress and increased adrenal activity.

Women with acne have lower levels of a specific hormone marker than women without acne.

A new method was created to test the effectiveness of Dihydrotestosterone (DHT) inhibitors, like finasteride and dutasteride, in human and fish cells. The results showed fish cells are more sensitive to these treatments, and dutasteride works better than finasteride in all tested cells.

Glucocorticoid receptors help regulate genes important for skin health and hair growth.

The treatment reduced hair growth and testosterone in women with excess hair and had some effects on stress responses.

Bone mineral and minocycline boost bone cell growth, aiding healing.

A new genetic disorder caused by an ODC1 mutation can be treated with DFMO.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

About 2.2% of women with symptoms of high male hormones have a mild form of congenital adrenal hyperplasia, and measuring a specific hormone level can accurately diagnose it.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.

Deuruxolitinib improves anxiety and depression in severe alopecia areata patients.

A new compound was made that might help treat diseases related to male hormones.

Clobetasol propionate 0.05% is more effective for hair re-growth in alopecia areata than tacrolimus 0.1%.

Substance P may worsen acne by increasing inflammation, but corticosteroids might help by reducing this effect.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.